Market Size of Global Hysteroscope Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Hysteroscope Market Analysis
The hysteroscope market is expected to register a CAGR of 6.6% over the forecast period.
The COVID-19 pandemic was a challenge for healthcare providers across the world as due to the high infectivity of SARS-CoV-2, the resources were diverted for the care of COVID-19 patients which affected the healthcare services other than COVID-19 which also affected the hysteroscope market. During the COVID-19 pandemic, patients are being limited to some procedures, and those who delay the procedure could result in adverse clinical outcomes. To minimize this adverse outcome many hospital settings followed pre-procedure, intra-procedure, and post-procedure guidelines. For instance, in April 2020, Meditrina announced that it has designed a single-use resecting hysteroscope to reduce the risks and delays associated with ineffective reprocessing during the COVID-19 pandemic. This helped as an alternative for uterine surgical procedures to continue during the pandemic. As we already moved closer toward the return of elective procedures, the hysteroscope market is expected to grow in coming future.
A hysteroscope is used to assess the uterus for diagnosing abnormalities like heavy bleeding, severe cramping, frequent miscarriages, or problems related to conceiving and endometrial cancers. Hysteroscopes are used mainly for two purposes-operative and diagnostics.
Increasing incidence of edometrial cancer, have been the primary driving factor for the growth of this market. According to International Agency for Research on Cancer, 2020 the incidence rate of endometrial cancer is increasing rapidly and is estimated to increase by more than 50% worldwide by 2040. Also, growing demand for minimally invasive diagnosis and treatment equipment and technological advancements in the development of new hysteroscope technologies have also helped the market to grow. For instance, in March 2020, Meditrina Inc has introduced Aveta System a new see and treat resecting hysteroscope with HD vision and the smallest insertion diameter. With increasing incidence of endometrial cancer and new advancements in the hysteroscopes the market is expected to grow during the study period.
However, lack of trained professionals and risk of infection due to equipment have been restraining the growth of this market.
